1. Home
  2. CMCT vs VRAX Comparison

CMCT vs VRAX Comparison

Compare CMCT & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Creative Media & Community Trust Corporation

CMCT

Creative Media & Community Trust Corporation

HOLD

Current Price

$4.51

Market Cap

2.8M

Sector

Real Estate

ML Signal

HOLD

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$0.36

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMCT
VRAX
Founded
1993
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8M
2.9M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
CMCT
VRAX
Price
$4.51
$0.36
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
4.4M
15.4M
Earning Date
11-14-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$113,028,000.00
$2,986.00
Revenue This Year
N/A
$217,274.83
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.56
$0.35
52 Week High
$73.68
$3.20

Technical Indicators

Market Signals
Indicator
CMCT
VRAX
Relative Strength Index (RSI) 49.65 39.07
Support Level $3.68 $0.35
Resistance Level $4.99 $0.43
Average True Range (ATR) 1.09 0.04
MACD 0.14 -0.01
Stochastic Oscillator 28.87 5.34

Price Performance

Historical Comparison
CMCT
VRAX

About CMCT Creative Media & Community Trust Corporation

Creative Media & Community Trust Corp is formed to invest in, own, and operate Class A and creative office investments in improving urban communities throughout the United States. It operates through segments such as office, hotel and multifamily properties and lending. The Office segment includes rental of office space and other tenant services, including tenant reimbursements, parking, and storage space rental. The Hotel segment relates to operations of hotel properties whereas, the lending segment refers to income from the yield and other related fee income earned on its loans receivable. The lending segment includes income recognized from the sale of government guaranteed portion of loans receivable, income from the yield on its loans receivable and other related fee income earned.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).

Share on Social Networks: